These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8932274)

  • 1. Blockade of proliferation and tumor necrosis factor-alpha production occurring during mixed lymphocyte reaction by interferon-gamma-specific natural antibodies contained in intravenous immunoglobulins.
    Toungouz M; Denys C; Dupont E
    Transplantation; 1996 Nov; 62(9):1292-6. PubMed ID: 8932274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of PD-L1 on monocytes: a new mechanism by which IVIg inhibits mixed lymphocyte reactions.
    Padet L; Loubaki L; Bazin R
    Immunobiology; 2014 Sep; 219(9):687-94. PubMed ID: 24875729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of IFN-gamma production by intravenous immunoglobulins during mixed lymphocyte reaction: consequences for proliferation and TNF-gamma production.
    Toungouz M; Denys C; Dupont E
    Transplant Proc; 1997; 29(1-2):1089. PubMed ID: 9123213
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased in vitro immunosuppressive action of anti-CMV and anti-HBs intravenous immunoglobulins due to higher amounts of interferon-gamma specific neutralizing antibodies.
    Denys C; Toungouz M; Dupont E
    Vox Sang; 1997; 72(4):247-50. PubMed ID: 9228717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of tumor necrosis factor and interferon gamma in graft-versus-host disease and related immunodeficiency.
    Wall DA; Sheehan KC
    Transplantation; 1994 Jan; 57(2):273-9. PubMed ID: 8310520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal control of interferon-gamma and tumor necrosis factor-alpha by interleukin-10 produced in response to one HLA-DR mismatch during the primary mixed lymphocyte reaction.
    Toungouz M; Denys C; de Groote D; Andrien M; Dupont E
    Transplantation; 1996 Feb; 61(3):497-502. PubMed ID: 8610367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of IVIg to identify potential miRNA targets for allograft rejection and GvHD therapy.
    Padet L; Loubaki L; Bazin R
    Clin Transplant; 2015 Jun; 29(6):543-6. PubMed ID: 25832981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytosine-Phosphorothionate-Guanine Oligodeoxynucleotides Exacerbates Hemophagocytosis by Inducing Tumor Necrosis Factor-Alpha Production in Mice after Bone Marrow Transplantation.
    Liu J; Guo YM; Onai N; Ohyagi H; Hirokawa M; Takahashi N; Tagawa H; Ubukawa K; Kobayashi I; Tezuka H; Minamiya Y; Ohteki T; Sawada K
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):627-636. PubMed ID: 26740374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal anti-TNF-alpha suppresses graft vs host disease reactions in an in vitro human skin model.
    Dickinson AM; Sviland L; Jackson G; Dunn J; Stephens S; Proctor SJ
    Cytokine; 1994 Mar; 6(2):141-6. PubMed ID: 8031996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
    Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF enhances CD4+ T cell alloproliferation, IFN-gamma responses, and intestinal graft-versus-host disease by IL-12-independent mechanisms.
    Brown GR; Lee EL; Thiele DL
    J Immunol; 2003 May; 170(10):5082-8. PubMed ID: 12734353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior immunomodulatory effects of intravenous immunoglobulins on human T-cells and dendritic cells: comparison to calcineurin inhibitors.
    Tha-In T; Metselaar HJ; Tilanus HW; Boor PP; Mancham S; Kuipers EJ; de Man RA; Kwekkeboom J
    Transplantation; 2006 Jun; 81(12):1725-34. PubMed ID: 16794540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-class II -DR humanized monoclonal antibody, IMMU-114, blocks allogeneic immune response.
    Park KH; Sawada T; Murakami T; Ishii Y; Yasuo M; Fuchinoue S; Goldenberg DM; Kubota K
    Am J Surg; 2012 Oct; 204(4):527-34. PubMed ID: 22658578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined neutralization of interferon gamma and tumor necrosis factor alpha induces IL-4 production but has no direct additive impact on parasite burden in splenic cultures of human visceral leishmaniasis.
    Singh N; Sundar S
    PLoS One; 2018; 13(6):e0199817. PubMed ID: 29953494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
    Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
    Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of alloimmune response in vitro by an IgM-enriched immunoglobulin preparation (Pentaglobin).
    Nachbaur D; Herold M; Gächter A; Niederwieser D
    Immunology; 1998 Jun; 94(2):279-83. PubMed ID: 9741353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the in vitro immunomodulatory activity of human intact immunoglobulin (7S IVIG), F(ab')2 fragments (5S IVIG) and Fc fragments. Evidence for post-transcriptional IL-2 modulation.
    Nachbaur D; Herold M; Eibl B; Glassl H; Schwaighofer H; Huber C; Gächter A; Pichl M; Niederwieser D
    Immunology; 1997 Feb; 90(2):212-8. PubMed ID: 9135549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Interferon-gamma in GVHD and GVL.
    Yang YG; Wang H; Asavaroengchai W; Dey BR
    Cell Mol Immunol; 2005 Oct; 2(5):323-9. PubMed ID: 16368058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.
    Imamura M; Hashino S; Kobayashi H; Kubayashi S; Hirano S; Minagawa T; Tanaka J; Fujii Y; Kobayashi M; Kasai M
    Bone Marrow Transplant; 1994 Jun; 13(6):745-51. PubMed ID: 7920309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.